EHAB Earnings Prediction
The chart below shows how EHAB performed 10 days before and after its earnings report, based on data from the past quarters. Typically, EHAB sees a +2.91% change in stock price 10 days leading up to the earnings, and a +1.58% change 10 days following the report. On the earnings day itself, the stock moves by +0.77%. This data can give you a slight idea of what to expect for the next quarter's release.
EHAB Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
253.60M
-1.82%
-2.69%
Gross Margin
44.83%
-0.69%
-3.61%
Operating Margin
5.21%
7.64%
-15.15%
Net Margin
-43.18%
4980.00%
-28886.67%
EPS
-2.20
-4300.00%
--
No Data Available
EHAB Earnings Analysis
Enhabit, Inc. Corporation (EHAB.N) Earnings Conference Call
Positive
EBITDA Growth Year-Over-Year: Consolidated adjusted EBITDA was $24.5 million, up $1.3 million or 5.6% year-over-year.
Admissions Growth Overview: Non-Medicare admissions grew 20.1%, driving total admissions growth of 5.6% year-over-year.
Home Health Revenue Increase: In the home health segment, revenue increased $5.2 million or 11% year-over-year due to an increase in patient days and increased Medicare reimbursement rates.
Census Growth Analysis: Our average daily census increased 6.9% year-over-year in Q3 compared to the prior year with 5% growth on a same-store basis.
Free Cash Flow Projection: We expect to generate $47 million to $55 million of free cash flow in 2024 as the fully year normalizes for the impact of working capital changes in the third quarter.
Negative
Quarterly Revenue Decline: Consolidated net revenue was $253.6 million for the third quarter down $4.7 million or 1.8% year-over-year.
Home Health EBITDA Decline: Home health adjusted EBITDA decreased $5.3 million or 12.7% year-over-year, primarily due to the decrease in revenue.
Home Health Revenue Decline: The decline in certifications was the primary driver of the $9.9 million or 4.7% decrease in home health revenue year-over-year.
Cost Per Visit Stability: The flat cost per visit year-over-year is expected as our increased census offsets the fixed costs that were added in 2023.
Home Health Reimbursement Challenges: The continued cuts to home health reimbursement are destabilizing the home health landscape and are detrimental to larger policy goals of providing equitable, high-quality health care to seniors.
EHAB FAQs
How does EHAB typically perform around its earnings report dates?
Is Enhabit, Inc. (EHAB) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
EHAB Earning Call Sentiment
Enhabit, Inc. (EHAB) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
EHAB.N
0.49%Positive
The earnings call presents mixed signals. Financial performance shows some positive signs like improved EBITDA and cash flow, but revenue decline and hurricane impacts are concerns. The Q&A highlights management's cautious optimism but lacks clarity on branch closures. The payer innovation strategy and potential United agreement offer growth potential, but uncertainties remain. Overall, the positive and negative factors balance out, suggesting a neutral stock price movement.
